Clinical Trial Detail

NCT ID NCT02642809
Title Pembrolizumab With Locally Delivered Radiation Therapy for the Initial Treatment of Metastatic Esophageal Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

esophagus adenocarcinoma

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.